LaNua Medical may be the newest face on the Irish medtech start-up scene but it has quickly raised €6 million for its device for treating internal bleeding and tumours, both benign and malignant. LaNua has built a device, Ecore, for surgeons and radiologists carrying out embolization procedures where the flow of blood needs to be controlled. The umbrella-shaped device is targeting the $2 billion embolization market, which is driven by a demand for more minimally invasive procedures to treat vascular diseases and cancer. According to the start-up’s founders, the device will complement other forms of embolization and reduce chances of…

Want to continue reading?

Introductory offer: Sign up today and pay €200 for an annual membership, a saving of €50.

Subscribe

Cancel at any time.

Are you already a member? .